These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 22309430)

  • 1. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits.
    Dorado P; Peñas-Lledó EM; Llerena A
    Pharmacogenomics; 2007 Nov; 8(11):1597-608. PubMed ID: 18034624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
    Preskorn SH; Kane CP; Lobello K; Nichols AI; Fayyad R; Buckley G; Focht K; Guico-Pabia CJ
    J Clin Psychiatry; 2013 Jun; 74(6):614-21. PubMed ID: 23541126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial.
    Fijal BA; Guo Y; Li SG; Ahl J; Goto T; Tanaka Y; Nisenbaum LK; Upadhyaya HP
    J Clin Pharmacol; 2015 Oct; 55(10):1167-74. PubMed ID: 25919121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.
    Pérez de los Cobos J; Siñol N; Trujols J; del Río E; Bañuls E; Luquero E; Menoyo A; Queraltó JM; Baiget M; Alvarez E
    Drug Alcohol Depend; 2007 Jul; 89(2-3):190-4. PubMed ID: 17234366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of
    Khalaj Z; Baratieh Z; Nikpour P; Khanahmad H; Mokarian F; Salehi R; Salehi M
    J Res Med Sci; 2019; 24():61. PubMed ID: 31523247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.
    Sistonen J; Sajantila A; Lao O; Corander J; Barbujani G; Fuselli S
    Pharmacogenet Genomics; 2007 Feb; 17(2):93-101. PubMed ID: 17301689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone.
    Köhnke MD; Lutz U; Wiatr G; Schwärzler F; Weller B; Schott K; Buchkremer G
    Eur J Clin Pharmacol; 2006 Apr; 62(4):333-4. PubMed ID: 16534635
    [No Abstract]   [Full Text] [Related]  

  • 8. Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
    Grözinger M; Dragicevic A; Hiemke C; Shams M; Müller MJ; Härtter S
    Pharmacopsychiatry; 2003 Jan; 36(1):3-6. PubMed ID: 12649767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically variable metabolism of antidepressants and neuroleptic drugs in man.
    Dahl ML; Bertilsson L
    Pharmacogenetics; 1993 Apr; 3(2):61-70. PubMed ID: 8100166
    [No Abstract]   [Full Text] [Related]  

  • 10. Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.
    Jerling M; Merlé Y; Mentré F; Mallet A
    Br J Clin Pharmacol; 1994 Nov; 38(5):453-62. PubMed ID: 7893588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population.
    Agúndez JA; Ledesma MC; Ladero JM; Benítez J
    Clin Pharmacol Ther; 1995 Mar; 57(3):265-9. PubMed ID: 7697944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report.
    Gahr M; Gastl R; Kölle MA; Schönfeldt-Lecuona C; Freudenmann RW
    J Med Case Rep; 2012 Feb; 6():49. PubMed ID: 22309430
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.